Meet the Team

Our Team

Meet our Elite
Regulatory Advisory 
Team

We understand that navigating the intricate world of regulation requires a multidimensional approach.

LFH Regulatory is your trusted partner in navigating the complex world of medical device and In Vitro Diagnostic Regulations.
Meet The Team LFH Regulatory

Laura Friedl-Hirst

Laura is the Managing Director & Principal Consultant at LFH Regulatory, the organisation she founded in June 2019 and one that has grown vastly since it was established. Her vision was to create a consultancy and a team of consultants that have a pragmatic approach for navigating companies to their end goals. She is as passionate then as she is now about creating a culture that is open, approachable, and flexible; she also promotes a great work-life balance.

After gaining a BSc (hons) in Medical Biology at The University of Huddersfield, she completed a placement year at DePuy and was introduced to the world of regulatory affairs. Since then, she has gained over 12 years’ extensive industry experience working with varying sized organisations and with a diverse range of medical device and in vitro diagnostics. Laura has a breadth of knowledge and expertise that spans over regulatory, quality, clinical and design & development.

As she continues to grow the consultancy, she is excited to see how far it will go.

Jessica Hambidge

Jessica is the Operations Director at LFH Regulatory. After achieving a BSc (Hons) in Biology at Queen Mary University of London, she completed an Internship in Project Management at a global pharmaceutical company, which is where her interest in medical devices and regulatory affairs started. Since then she has worked on a large variety of devices and worked on global registrations for Class I SaMD to Class III Implants, in small start-up organisations to large global companies.

The last few years she has specialised in regulatory strategy for software and digital health tools in global markets and the many ways in which software can be leveraged in healthcare; from data collection tools in drug development to their use in disease management and beyond.

Zara Malik

Zara is Head of Regulatory Affairs at LFH Regulatory. She attended the University of Leicester where she gained a BSc (Hons) in Biological Sciences.

Zara started her career in 2015 working in R&D for IVDs, before moving over to Quality and Regulatory. Since then, Zara moved over to working with medical devices, specifically sterile devices, SaMD and AIaMDs.

Her extensive background covers full creation, implementation and maintenance of ISO 13485 compliant QMS, validation and verification activities, conducting Internal audits, managing notified body audits, creation and maintenance of technical documentation as well as Risk Management.

Zara’s experience also includes developing and executing regulatory strategy plans, monitoring the regulatory landscape.

She aims to continue growing in the regulatory landscape in the med tech sector and contribute to innovation which can ultimately benefit patient health.

Sarah Pavitt

Sarah is the Principal Consultant at LFH Regulatory.  She holds a degree in Analytical Chemistry and began her career in the pharmaceutical industry, where she spent 12 years gaining extensive experience. She then transitioned into the medical device sector, working in regulatory roles for five years within various medical device companies.

For the past 10 years, Sarah has worked as a regulatory and quality consultant, supporting small to medium-sized medical device companies in achieving and maintaining regulatory compliance.

Her expertise spans the creation of technical documentation for Class I to Class III devices, including electromedical equipment, software as a medical device (SaMD), and life-supporting devices, for both EU and UK markets. She has also successfully supported numerous regulatory submissions and audits, including those related to ISO 13485 quality management systems.

She aims to continue providing expert, client-centric medical device support and advice to manufacturers wishing to place both established and novel devices on the market to meet existing and future patient needs.

Dr Yupei Xiao

Yupei is the Clinical and Regulatory Consultant at LFH Regulatory. She is an expert in Performance Evaluation and Post Market Surveillance documentation of Molecular Diagnostic and Companion Diagnostic IVDs.

After her PhD in Respiratory Medicine at the University of Hull, Yupei worked as Post-doc Research Fellow at Hull York Medical School (Castle Hill Hospital, Hull). Yupei has profound experiences in managing NHS funded oncology trials, which include drafting study protocol, preparing the Ethics application, data analysis & interpretation, and manuscript preparation for journal submission.

She has over 8 years’ extensive industry experience working with varying sized organisations and with a diverse range of in vitro diagnostics products. Yupei has a breadth of knowledge that includes Regulatory, Quality, Design & Development, and Medical Writing. Additionally, she is also experienced in managing the investigator let studies (ILS) in IVD products.

Alexander Madell

Alexander is a Quality Assurance and Regulatory Affairs Consultant at LFH Regulatory. He obtained a BSc (Hons) in Biomedical Sciences from Durham University before completing a MSc specialising in Haematology at the University of Westminster. Alexander commenced his professional career in 2020, supporting the transfer of numerous pharmaceutical Marketing Authorisations at the MHRA. From here, Alexander moved to the medical devices sector and has worked with several leading manufacturers on a range of devices, spanning from class I to class IIb.

Notably, Alexander has utilised his keen analytical skills to navigate some key complex regulatory changes, including Brexit and Swixit, to ensure seamless market access and sustained compliance. Further, his responsibilities have included the development and maintenance of device technical files, performing regulatory impact assessments and co-ordinating regulatory responses across all aspects of change management.

With a strong focus on continued learning, Alexander is dedicated to applying his scientific background in support of the safe and timely introduction of innovative medical technologies that enhance patient care.

Amrita Bansal

Amrita is the Quality Assurance and Regulatory Affairs Consultant at LFH Regulatory. She earned her BSc (Hons) in Biomedical Science from the University of Birmingham in 2019 and embarked on her professional journey shortly thereafter. Initially, she worked in Medical Information and Product Technical Complaints for Pharmaceuticals and Combination Products. Later, she transitioned to Regulatory Affairs, gaining expertise across all Classes of Medical Devices.

Amrita’s extensive background includes creating and developing technical files from scratch, devising and executing regulatory pathways and strategies. She has streamlined processes for generating and submitting new registration packs, renewal packs, and change notifications for medical devices on a global scale. Additionally, she has authored and implemented SOPs and Work Instructions to enhance Quality Management System (QMS) processes. As part of her role, she leads Regulatory Intelligence efforts, overseeing impact assessments and global regulatory surveillance.

Driven by a passion for patient safety, Amrita remains committed to contributing to the field of medical devices. She continues to learn and grow within the regulatory landscape.

Chloe Johnson

Chloe is the Junior QA/RA Consultant at LFH Regulatory.  Building upon a foundation in academic neuroscience research, she completed a BSc in Neuroscience in 2016 from the University of Manchester before gaining vocational experience in pharmaceutical data intelligence. She later pursued an MSc in Clinical Neuroscience at UCL, focusing on utilising transcranial magnetic stimulation (TMS) combined with EEG as a biomarker for epilepsy.

Following her academic research, Chloe transitioned into clinical trials, acquiring hands-on experience in trial start-up and study management. In 2023, she expanded her expertise into regulatory affairs within the medical device industry, where she developed and maintained comprehensive technical file documentation, including clinical evaluations, risk management files, and post-market evaluations in compliance with UK and EU market requirements.

In the past year, Chloe further expanded her role to include Quality Management Systems (QMS) responsibilities by implementing and updating SOPs and supporting audits to streamline quality systems in accordance with ISO 13485 standards.

She is excited to leverage her scientific background and regulatory experience to support the delivery of safe and efficacious novel healthcare solutions and is committed to continuous learning and contributing positively to LFH Regulatory’s ongoing success.

Lucy Curtis

With a strong background in business administration and quality management, Lucy brings a wealth of experience in ensuring smooth operations and process improvement. Throughout her career, she has consistently demonstrated an exceptional ability to manage complex data, streamline processes, and drive efficiency across various functions. 

Previously, Lucy worked within the quality department of a custom implant company, where she gained in-depth experience in CAPA (Corrective and Preventive Actions), QMS (Quality Management Systems), training, and auditing. This experience has equipped her with a deep understanding of regulatory compliance and the critical role that quality control plays in the medical industry. 

As Business Administrator, Lucy applies her organisational expertise and attention to detail to support the company’s goals and ensure that operations run smoothly. With a passion for continuous improvement and an unwavering commitment to excellence, Lucy is dedicated to helping the team achieve operational success and deliver results.